VANCOUVER, Feb. 27 /CNW/ - iCo Therapeutics Inc. (TSX-V: ICO) announced
today that Dr. Peter Hnik, iCo's Chief Medical Officer, has been invited to
give a presentation discussing iCo-007 at the 7th International Symposium on
Ocular Pharmacology and Therapeutics (ISOPT) in Budapest, Hungary
(http://www.kenes.com/isopt/). Dr. Hnik's presentation, entitled, "iCo-007, a
VEGF "+" Agent, for the Potential Treatment of Diabetic Macular Edema and
Diabetic Retinopathy", will take place on March 2nd, 2008.
